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Syphilis is a chronic, complex, sexually transmitted disease of humans caused 
by Treponema pallidum.  Despite intensive research, the parameters affecting the 
pathogenesis  of syphilis  remain  substantially  undefined,  due  primarily  to  the 
inability to culture large numbers  of T. pallidum  in vitro.  Examination  of the 
host response to T. pallidum has therefore been one of the few effective tools for 
studying  the  consequences  of treponemal  infection.  Resistance  to  reinfection 
develops during the course of the disease and is elicited in human latent syphilitic 
patients (3-5) as well as in the rabbit (1-8) and hamster (9) experimental models. 
Evidence for the involvement of both humoral  and cell-mediated immunity in 
the response of the host to infection has been presented (1, 2,  10,  11). 
The fact that humoral immunity may play a significant role in the developing 
immune response is implicated by the ability of antibody to block the attachment 
of T. pallidum  to tissue culture cells in vitro (12,  13), the immobilization  of T. 
pallidum by antibody in vitro (14,  15), the in vitro-in  vivo neutralization  of T. 
pallidum  (16),  and  immune  passive transfer  experiments  using immune  serum 
(17-23) or IgG purified from immune serum (24). The passive protection studies 
have  shown  either  complete  or  partial  but  definitive  protection  against  T. 
pallidum  infection  by reducing,  delaying,  and/or  preventing  lesions  following 
the passive immunization of rabbits (17-24). 
The persistence of the organism, despite a high "protective" antibody titer (1, 
2),  indicates  that  antibody  alone  cannot  eradicate  the  organisms  during  T. 
pallidum infection (1,  2).  Considerable controversy exists, however, concerning 
the  role  of cell-mediated  immunity  in  syphilis.  Several  cell-mediated  immune 
mechanisms have been suggested to have a role in the response of the host to T. 
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paUidum infection. These mechanisms have been recently reviewed in detail (10, 
11).  Though the individual roles of cell-mediated and humoral immunity have 
not been precisely characterized, the host immune response to T. pallidum may 
very well include components of each. 
Several investigators have exploited the humoral immune response during T. 
paUidum infection to identify components of T. pallidum that are antigenic and/ 
or immunogenic. Baseman and Hayes (25) and Alderete and Baseman (26), using 
polyclonal  antisera  from  rabbits  or  humans,  identified  I 1  outer  membrane 
proteins of T. paUidum, three of which, with the apparent molecular weights of 
72,000-89,000  (72-89  K), 28-29.5  K, and 25.5-26  K, were relatively immu- 
nogenic.  Using  serum  from  hyperimmunized  rabbits,  Lukehart  et  al.  (27), 
detected six antigens with molecular weights ranging from 30 to 48 K and two 
additional antigens at 12 and 14 K. Hanff and colleagues (28) used human serum 
from syphilitic patients to detect 14 T. pallidum-specific antigens, ranging from 
15 to 94 K in molecular weight. In a further study with human syphilitic serum, 
Hanff et al. (29) suggested that the major antigenic proteins of T. pallidum are 
comprised of four polypeptides of 30-45  K and two smaller molecular weight 
polypeptides of 15-16  K.  In  an  extension of these results,  Moskophidis and 
colleagues (30)  used human serum and detected similar proteins reported by 
Hanff et al. (28,  29), in addition to proteins with molecular weights of 37,  38, 
59 K, and 69 K. 
The use of polyvalent antisera in conventional antigen survey studies detected 
immunogenic T.  pallidum  components.  However,  the  relative  importance  of 
these antigens has been difficult to assess.  Alternatively, monoclonal antibodies 
against T. paUidum provide a unique opportunity to use antibodies of predefined 
specificity for use in in vitro studies, similar to those performed in the past, as 
well as for use within in vivo experiments. Functional studies using monoclonal 
antibodies potentially allow the assessment of biological relevance to prospective 
immunogens, and  possibly also  to  the polyclonal antibodies normally elicited 
against them. On this basis, a defined working hypothesis relative to the biological 
importance of an immunogen can be formulated and tested in further studies. 
Subsequent in vitro techniques can then be used to characterize the immunogen 
and to investigate its potential role in the immune response of the host. 
Using this novel approach, a  monoclonal antibody directed against an abun- 
dant,  immunodominant,  47,000  mol  wt,  surface-exposed  immunogen  of  T. 
pallidum has been shown  to  possess  reactivities in  the microhemagglutination 
assay for T. pallidum antibodies (MHA-TP test)  a and the Treponema pallidum 
immobilization (TPI) test, as well as to block significantly the attachment of T. 
pallidum to host cells in vitro. Moreover, this monoclonal antibody was capable 
of neutralizing T. pallidum in the in vitro-in vivo neutralization test of Bishop 
l Abbreviations used in this paper:  Abs, ABS, absorbed with T. phagedenis biotype Reiter; DOC, 
desoxycholate; IRS, immune rabbit serum; LPO, lactoperoxidase;/3-ME,2-ME,  beta-mercaptoethanol; 
MET, methionine; MHA-TP, microhemagglutination assay for T. pallidum antibodies; mAb, mono- 
clonal antibody; NET, TNE,  150 mM NaCI, 5 mM EDTA, 50 mM Tris pH 7.2;  NRS, serum from 
VDRL nonreactive normal adult rabbits; NRT, normal rabbit testicular tissue; PBI, phosphate buffer 
with  50  mM  NaI;  PBS,  phosphate-buffered saline; PMSF, phenylmethylsulfonyl fluoride;  RIA, 
radioimmunoassay; RIP, radioimmunoprecipitation; SDS, sodium dodecyl sulfate; SDS-PAGE,  so- 
dium dodecyl sulfate polyacrylamide gel electrophoresis; Tp, Treponema paUidura; TPI, 7". pallidura 
immobilization; VDRL, Venereal Disease Research Laboratory. 1406  MAJOR  SURFACE IMMUNOGEN  OF  T.  PALLIDUM 
and  Miller  (16).  These  results  serve  to  establish  the  47,000  mol  wt  surface 
antigen as the first functionally defined, major surface immunogen of T. pallidura. 
Materials and  Methods 
Treponemal Strains.  T. pallidum  subspecies pallidum  (Nichols strain) was propagated 
using standard intratesticular inoculation of New Zealand White rabbits with 2-5 ×  107 
T. paUidum per testicle as previously described (31). 
T. phagedenis biotype Reiter (Reiter) was cultivated in vitro through maintenance in 
BBL thioglycoilate medium 135C supplemented with either 10% heat-inactivated (56 ° C, 
30  min) bovine or  hemolyzed rabbit serum  (Pel-Freez  Biologicals,  Rogers,  AR).  The 
bacteria were passaged monthly and processed as described previously (3 I). 
Animals.  Adult male New Zealand White rabbits, obtained from Hickory Hill Farms, 
Flint, TX, were used both for maintenance of T. pallidum  and for neutralization assays. 
The animals were examined for the absence of T. paraluis-cunieuli infection both sero- 
logically (Venereal  Disease Research  Laboratory [VDRL]) (32)  and  clinically.  Animals 
were housed at 17-20°C and were given antibiotic-free food and water ad libitum. 
Antibodies, Sera, and Antisera.  Monocional antibodies directed specifically against T. 
paltidum were obtained, maintained, and characterized as described previously (31). Serum 
from VDRL  nonreactive normal adult  rabbits (NRS) was collected and  in  some cases 
heated at 56°C  for 30 min to inactivate complement. Immune rabbit serum (IRS) was 
obtained from rabbits intratesticularly infected with 2-5 × 107 T. pallidum  (Nichols) per 
testicle; immune serum was then collected from these rabbits 3-12 mo after a firm orchitis 
in each testicle (20).  The rabbits were shown to be "chancre immune" when challenged 
intradermally with  1 × 105 T. paUidum. Normal mouse serum was obtained from unino- 
culated BALB/c mice, and in some cases was heated at 560C for 30 min. Mouse anti-T. 
pallidum serum was obtained after the immunization of adult BALB/c mice as described 
previously (31).  IgG from normal and immune rabbit sera was purified using a modifica- 
tion  of established methods (24,  33).  Affinity-purified goat anti-rabbit  IgG, goat anti- 
mouse IgM (mu chain specific), sheep anti-mouse IgG, and goat anti-mouse IgM were 
obtained from Cappei Laboratories (Cochranville, PA). Affinity-purified rabbit IgM was 
obtained from Pel-Freez Biologicals. 
Purification ofT. pallidum.  T. pallidura for analytical studies was purified using Percoll 
(Pharmacia, Piscataway, NJ) density gradient centrifugation (34,  35).  After Percoll puri- 
fication, T. pallidum  cells were washed free of residual Percoll by centrifugation (13,500 
g) several times in phosphate-buffered saline (PBS)  (31) until the treponemes formed a 
dense pellet at the  bottom of a  microcentrifuge tube,  rather than  layering on  top of 
contaminating Percoll particles. 
Radiolabeling of Treponeraes and Monoclonal Antibodies.  Initially (method  1) (36,  37), 
Percoll-purified T. paUidum (5-10 ×  108) were suspended in 200 #1 of PBS.  A 50 t~l vol 
of 0.03% H20~ (freshly prepared using 5 #1 of a 30% stock solution of H~O~ in 4.995 ml 
of PBS),  20  #1  of Na-I  1~5  (2  mCi;  New  England  Nuclear,  Boston,  MA),  and  50  gl  of 
lactoperoxidase (LPO) (Sigma Chemical Co., St. Louis, MO) were combined with trepo- 
nemes, mixed well,  and allowed to incubate at room temperature for 4 rain. 50 #1 each 
of 0.03%  H~O~ and LPO were added at 4 and 8 min after initiation of the reaction. At 
12  min after time zero, 50 #1 of H20~ was again added and allowed to incubate for 4 
additional minutes, the reaction was stopped by addition of phosphate buffer containing 
50 mM NaI (PBI). Labeled cells were washed by multiple centrifugations (13,000 g) in 
PBI. The cells were resuspended in PBS for use in assays. More recently, the LPO labeling 
procedure reported by Alderete and Baseman (26) for T. pallidum  has also been used 
successfully (method 2). Labeling of monoclonal antibodies with 125I using chloramine T 
was performed as described (38). 
Radioimmunoprecipitation.  Radioimmunoprecipitation (RIP) was adapted from Hansen 
et al. (36).  ~1  ×  107 cpm of II~5-1abeled treponemes (1-3 counts per treponeme) were 
solubilized at 37°C in 5 ml of solubilization buffer composed of 10 mM Tris-HC1,  150 
mM NaCI, 5 mM EDTA, 1% (vol/vol)Triton X-100, 0.2% (vol/vol)sodium desoxycholate, JONES  ET AL.  1407 
and 0.1% sodium dodecyl sulfate, pH 7.6. The partially solubilized (~70-80%) suspension 
was centrifuged at 30,000 g (16°C) for 1 h, and the supernatant containing solubilized T. 
pallidum antigens was removed from the pellet. To this supernatant was added either 10- 
20 #g of monoclonal antibody, 200 ~1 of PBS, normal rabbit serum, immune rabbit serum, 
normal mouse serum, or mouse anti-T, pallidum serum, and the mixture was rocked for 
1 h at 25°C. A 200-~1 suspension of prewashed protein A-bearing Staphylococcus aureus 
(Cowan I strain), prepared by the method of Kessler (39), was subsequently added to the 
suspension, which was rocked for 1 h at 4°C. The samples were centrifuged at 3,000 g 
for 20 rain, and the supernatant was discarded. The antigen-antibody-Staphylococcus pellet 
was then washed five times by centrifugation at  13,000 g in fresh solubilization buffer. 
The final pellet was suspended in digestion buffer (0.0625 M Tris-HCI, 10% glycerol, 2% 
SDS,  pH  6.8),  heated  to  100°C  for  5  rain,  and  cooled to  room  temperature.  The 
supernatant was removed and collected after centrifugation. Beta-mercaptoethanol to a 
final concentration of 5% was then added to each sample, and the samples were heated 
to 100°C for 5 min and allowed to cool before use in sodium dodecyl suifate-polyacryl- 
amide gel electrophoresis (SDS-PAGE). Radioimmunoprecipitated samples were subjected 
to discontinuous SDS-PAGE (4% acrylamide stacking gel and  10% acrylamide running 
gel) (40). Dried gels were exposed to Fuji x-ray film with an enhancing screen (Kodak 
Cronex Lightening Plus) for autoradiography. 
Radioimmunoassays.  Radioimmunoassays (RIA)  were performed as described previ- 
ously (31) using various antibodies and preparations as antigens. 
Iramunoblots.  Immunoblots were performed as previously described (41-43). 
Serological Tests for  Syphilis.  Mouse anti-T, pallidum  monoclonal antibodies,  either 
affinity purified (44) or found within hybridoma clone supernatants (31), were tested for 
their ability to immobilize T. pallidum  (Nichols) in the T. pallidum immobilization (TPI) 
test. The TPI assay was carried out, with minor modifications, as described (45). Penicil- 
linase was incorporated into the test procedure due to the possibility of residual penicillin 
in the hybridoma clone supernatants (31). 
The MHA-TP (Sera-Tek; Ames Division, Miles  Laboratories, Elkhart,  IN) was per- 
formed on  both respective hybridoma clone supernatants and  affinity-purified ami-T. 
pallidum monoclonal antibodies, according to the methods described by the manufacturer 
(46). 
In Vitro-In Vivo Neutralization Test.  The in vitro-in vivo neutralization test of Bishop 
and Miller was performed essentially as described previously (16).  Briefly, 1  ×  104  T. 
paUidum per ml, rabbit serum as a source of  complement, and antibody (either monoclonal 
or polyclonal) were incubated for 16 h at 34°C under an atmosphere of 95% N, plus 5% 
CO~. After incubation, 0.1  ml portions of reaction mixtures were injected intradermally 
into clipped rabbit backs. The sites were observed daily for lesion development; the delay 
and nature of lesion development was observed at the test sites and compared with both 
positive (T.  pallidum  plus  complement  plus  immune  rabbit  serum)  and  negative  (T. 
paUidum plus complement plus normal rabbit serum, or T. pallidum plus antibody) control 
sites.  Percent neutralization of the virulent organisms was  extrapolated from previous 
data  examining  the  7".  pallidum  dose  response and  subsequent  time  delay for lesion 
development after intradermal injection (7, 47, 48). 
Results 
Spectrum  of T.  pallidum  Immunogens.  Solubilized  125I-labeled antigens  of T. 
pallidum  were immunoprecipitated and subjected to SDS-PAGE analysis. Fig.  1 
shows that T. pallidum antigens radioimmunoprecipitated in this manner ranged 
in molecular weight from approximately 13 to 47 K, with the major immunogens 
at 36 and  47  K.  The 47-K mol wt antigen appeared to be highly dominant in 
the profile. To determine those immunogens specific for pathogenic treponemes, 
similar RIP analyses using IRS (200 ~1) preabsorbed with solubilized Reiter (3 × 
109) cells were employed. In Fig.  2, lanes I, 3, and 5 serve as negative controls, 1408  MAJOR  SURFACE  IMMUNOGEN  OF  T.  PALL1DUM 
FIGURE  l.  Radioimmunoprecipitation  and SDS-PAGE of l~5I-labeled, solubilized  T. pallidura. 
Anti-/'. pallidum  immune rabbit serum (IRS) was used as the precipitating antibody source. 
Precipitable products were detected by autoradiography. 
FIGURE  2.  Radioimmunoprecipitation and SDS-P AGE of ~e51-1abeled,  solubilized  T. pallidum. 
Precipitable products were detected by autoradiography. Lanes 1, 3, and 5 employ normal 
rabbit serum (NRS) absorbed with T. phagedenis biotype Reiter (Reiter-ABS), normal rabbit 
serum (NRS),  and normal mouse serum (NMS),  respectively, as controls. Lanes 2 and 4 used 
anti-T, pallidum  immune rabbit serum (IRS) absorbed with the Reiter treponeme (Reiter-ABS) 
and anti-T,  pallidura  immune rabbit serum (IRS)  as antibody sources, respectively. Lane 6 
employed mouse anti-T, pallidum  (Tp) serum. 
showing that all sera from  either normal  rabbits or normal  mice did not immu- 
noprecipitate  detectable  antigens  of  T.  pallidum.  Lanes  4  and  6,  using  serum 
from  infected immune  rabbits or immunized  mice, respectively, showed  similar 
immunogenicity  of the antigens in rabbits and mice. Furthermore,  lane 2  shows 
that preabsorption of IRS with Reiter did not alter the antigenic pattern obtained 
(as seen in lane 4) when  untreated  IRS was used.  These  results suggest that the JONES ET  AL.  1409 
six  major  antigens  of T.  paUidum  detected by radioimmunoprecipitation  with 
IRS are not found in similar configuration in the representative nonpathogen. 
Reiter cells surface labeled with 1~I were used in similar RIP experiments. As 
shown in lanes I and 2 of Fig. 3, NRS or NRS absorbed with the Reiter treponeme 
(NRS-ABS), respectively, revealed the faint presence of apparent immunoprecip- 
itable products similar to those observed when using PBS; these results are most 
likely due to a degree of nonspecific binding.  Lanes 3 and 4 of Fig.  3 show the 
results of anti-T,  pallidum  IRS and  anti-T,  pallidum  IRS absorbed with  Reiter 
(IRS-ABS).  Lane  4  shows results  using  Reiter-absorbed immune  rabbit  serum, 
and  demonstrates  the absence of antigens  previously detected when  using un- 
treated  immune  rabbit serum (lane 3).  The antigens  in  lane 3  are thus  Reiter 
antigens,  detectable using  IRS from rabbits infected with  T.  pallidum  and  are 
cross-reactive with antibodies generated during T. pallidum  infection.  Note that 
lanes 3 and 4 lack any antigen with a  molecular weight of 47 K, indicating that 
the 47 K antigen is not detectable in the Reiter treponeme using this technique. 
Furthermore,  the overall antigenic profile observed (Fig. 3, lane 3) through  the 
immunoprecipitation  of ~SI-labeled Reiter with immune rabbit serum is dissim- 
ilar from that observed when the same IRS is used to immunoprecipitate  ~SI-T. 
pallidum (Figs.  1 and 2). 
Screening of a Monoclonal Antibody Panel.  A monoclonal antibody (mAb) panel 
reported by Robertson et al. (31), was screened for reactivity in an RIP with the 
immunogens previously detected in  Figs.  1 and  2  using polyvalent IRS.  Fig.  4 
shows the results obtained using one particular mAb (11E3), a murine monoclo- 
hal  antibody of the  subclass IgG2a.  Lane  1  (Fig.  4) displays the  reproducible 
immunogenic pattern obtained using polyvalent IRS. Lane 2 (Fig. 4) shows that 
the mAb (11E3) efficiently immunoprecipitated the 47 K mol wt antigen normally 
detected when IRS was used as the antibody source in RIP analysis. The relative 
FIGURE 3.  Radioimmunoprecipitation  and SDS-PAGE of liSl-labeled, solubilized Treponeraa 
phagedenis biotype Reiter cells. Precipitable products were detected by autoradiography. In 
lanes 1 and 2, NRS and T. phagedenis biotype Reiter-absorbed  NRS (Reiter-ABS) were used as 
negative serum controls. Lanes 3 and 4 employed anti-T, pallidum IRS and anti-T, pallidum 
IRS absorbed with the Reiter treponeme (Reiter-ABS). Lane 5 used anti-47-K immunogen (of 
T. pallidum) mAb 1  IE3 as precipitating antibody. 1410  MAJOR  SURFACE  IMMUNOGEN  OF  T.  PALLIDUM 
FIGURE 4.  Radioimmunoprecipitation and SDS-PAGE of ~zSI-labeled, solubilized, T. palli- 
dum.  Either  immune rabbit  serum  (IRS)  (lane  1)  or  mAb  lIE3  (lane  2)  were  used  as 
precipitating antibody sources, l IE3, monoclonal antibody 11E3. 
FIGURE 5.  Immunoblots of sonicated T. pallidum  and T. phagedenis biotype Reiter using 
anti-47 K tool wt immunogen (of T. #allidum)  mAb 11E3 and 13C6. Solubilized antigens of 
T. pallidum  or T. phagedenis biotype Reiter were detected after SDS-PAGE and protein transfer 
by incubating nitrocellulose strips with mAb I 1E3  (lanes 1 and 2) or  13C6 (lanes 3 and 4) 
before immunologic detection with horseradish peroxidase-conjugated goat anti-mouse IgG. 
Tp, T. pallidum;  11E3,  mAb llE3;  13C6,  monoclonal antibody 13C6; Reiter, T. phagedenis 
biotype Reiter. 
intensity of the 47  K band immunoprecipitated by the mAb suggests that this 
antigen is found abundantly in  T. pallidum,  is very efficiently labeled,  and/or 
that the mAb possesses high binding affinity for the antigen.  Fig.  5  shows the 
results of immunobiotting using the same mAb reacted against either T. pallidum 
or the Reiter treponeme as antigens.  In lanes  1 and 3,  where T. pallidum  was JONES  ET  AL.  141 1 
probed with mAb  11E3 or an additional mAb directed against the 47 K mol wt 
antigen (13C6),  mAb  11E3  reacted with the 47  K  antigen of T. pallidum,  but 
not with any similarly detectable antigen(s) of Reiter (lanes 2 and 4). 
To  ascertain  that  the  47  K  mol  wt antigen was  the  same antigen observed 
when using polyvalent antisera (IRS) in either RIP or immunoblots, a  variation 
of the RIP assay was performed.  In Fig. 6, lanes 2 and 3  are negative controls, 
demonstrating a  lack of nonspecific binding. Lane 5 shows the normal immuno- 
genic profile when polyvalent immune rabbit serum is used in the RIP. In Fig. 
6, lane 6, the 47  K mol wt antigen of T. paUidum is detected using mAb  11E3. 
In lane 7, labeled T. pallidum cells were solubilized and preabsorbed twice with 
mAb  11E3,  followed by incubation with staphylococcal protein A-bearing cells 
and centrifugation to remove the mAb-antigen complexes. The remaining solu- 
bilized antigen in the supernatant was then incubated with polyvalent IRS as the 
final immunoprecipitating antibody source. As is evident in lane 7, preincubation 
with mAb effectively removed the 47 K mol wt antigen, resulting in an absence 
of that component when IRS was subsequently employed. 
Screening of Anti-47-K mAb for Reactivity with Rabbit IgG or IgM.  Growth of T. 
paUidum  in vivo results in binding of host anti-T, pallidum antibodies (49) and 
other proteins (50) to the organism. For this reason, and because the 47  K mol 
wt antigen is near the molecular weight for rabbit immunoglobulin heavy chain 
(~50 K) (51), mAb was tested to ensure that its reactivity was specifically directed 
against T. pallidum immunogens and not against anti-T, pallidum antibodies that 
may be bound to T. pallidum.  RIA were used to quantitate the reactivity of ~25I- 
labeled mAb  11E3 with several sources of other antibodies bound to assay wells 
as test antigens.  Because mAb  11 E3  is of the mouse subclass IgG2a, goat anti- 
rabbit  IgG and  goat anti-mouse  IgM  (mu  chain  specific) antibodies  served  as 
FIGURE 6.  Radioimmunoprecipitation  and SDS-P  AGE of125I-labeled, solubilized  T. pallidura. 
Lanes 2 and 3 were controls, employing phosphate-buffered saline (PBS) and normal rabbit 
serum (NRS), respectively,  as sham antibody sources. Lane 5 employed  anti-T, pallidura  immune 
rabbit serum (1RS). Lane 6 utilized anti-/', pallidura mAb 11E3. Lane 7 displays  the immuno- 
precipitable products obtained following preabsorption of T. pallidura antigens with mAb 
11 E3 (twice), followed  by detection of the remaining antigen with immune rabbit serum (IRS). 
Lane I shows molecular weight standards. Lane 8 used late latent human syphilitic serum 
(HSS-LL) as precipitating antibody. 1412  MAJOR SURFACE IMMUNOGEN OF  T.  PALLIDUM 
negative control antigens in the RIA, resulting in background binding levels of 
mAb  in  the  RIA.  A  positive  control  antigen  included sheep  anti-mouse  IgG, 
which showed high specific binding to mAb  11E3 when ~25I-labeled  mAb  1 1E3 
was used as a  probe.  Test antigens also included IgG purified from NRS,  IgG 
from  IRS,  and  normal  rabbit  testicular  tissue  (1,  2,  49,  50).  As presented  in 
Table I, sheep anti-mouse IgG (the positive control) showed 12~I-labeled  mono- 
clonal antibody 1 1  E3 counts bound to be about 20-fold higher than those of the 
negative controls or other test antigens, indicating that the test antigens and the 
negative controls  both  showed background  levels of reactivity in  RIA.  Sheep 
anti-mouse  IgG  reacted  strongly with  mAb  1 1E3,  as  expected.  These  results 
indicated that mAb 1 1  E3 has no detectable reactivity with IgG from both normal 
and  immune  rabbit  serum,  and  lacks  reactivity  with  normal  rabbit  testicular 
tissue.  Table  II  shows  similar  experiments  using  goat  anti-mouse  IgM  as  a 
negative control antigen, and sheep anti-mouse IgG again as the positive control 
antigen (with  12~I-labeled monoclonal antibody  1 1E3  as the probe).  This assay 
investigated the possible reactivity between mAb  1 1  E3 and pooled rabbit IgM. 
The  reactivity  of rabbit  IgM  test  antigen  was  equivalent  to  RIA  reactivity 
observed for the negative control, indicating a  lack of reactivity of mAb  11 E3 
with rabbit IgM. 
Serological  Test for  Syphilis.  mAb  1 1E3  proved  to  be  reactive  in  both  the 
TABLE  I 
Reactivity of 125I-labeled Anti-T. pallidura Monoclonal Antibody 
11E3 with Selected Antigens by Radioimmunoassay 
Antigens*  1251 bound* 
cpm 
Controls: 
(-) Goat anti-rabbit IgG  4,154 4- 698 
(-) Goat anti-mouse IgM (•  chain specific)  4,475 4- 512 
(+) Sheep anti-mouse IgG  84,507 _ 6,040 
Tests: 
NRS IgG  4,617 ___ 704 
IRS IgG  4,974 4- 616 
NRT (testicular)  4,122 4- 444 
* Abbreviations: NRS, normal rabbit serum; IRS, immune rabbit serum; 
NRT, normal rabbit testicular tissue. 
* Mean + SD; n = 12. 
TABLE II 
Reactivity of ~2~I-Labeled Anti-T. pallidum Monoclonal Antibody 
I IE3 with Selected Antigens by Radioiramunoassay 
Antigens  ~sI bound* 
cpm 
Controls: 
(-) Goat anti-mouse IgM (u chain specific)  1,303 4- 273 
(+) Sheep anti-mouse IgG  79,303 4- 5,057 
Test: 
Rabbit lgM  1,664 4- 547 
*Mean-SD;n= 12. JONES  ET AL.  1413 
TABLE III 
In Vitro-In Vivo Neutralization ofT. pallidum  by Anti-47,000-d Immunogen Monoclonal 
Antibody 11E3 
Contents of  No. of  Average  Delay  time to  Neutrali- 
Experi-  Assay tube  in vitro  rabbit  lesion  de-  from  zation 
sites in-  control  (killing)!  ment  designation  assay tube*  jected*  vel°p7  lesions 
ment e 
d  d  % 
Negative control  NRS  4  12  NA  0 
Positive control  IRS + NRS  4  0  oo  ~  100 
Experimental  200 #g mAb +  4  27  15  99 
NRS 
Negative control  NRS  4  15  NA  0 
Positive control  IRS + NRS  4  0  00  100 
Experimental  200 ~g mAb +  4  0  00  100 
NRS 
* All tubes contained 1 x  104 viable T. pallidum per ml. 
* One site injected intradermally on each of four different rabbits. 
0 Lesion delays never varied more than _+ 1 d. 
m  (7, 47,  48). 
I No lesions observed after 77 d. 
NA, not applicable. 
MHA-TP  and  TPI  tests.  These  results  suggest  a  relative  abundance  of the 
antigen, and a surface-exposed location on T. pallidura, respectively. 
In  Vitro-In  Vivo Neutralization  Test.  Table III provides data obtained  from 
two independent neutralization experiments. Anti-47 K immunogen monoclonal 
antibody  caused  a  significant  delay  in  or  absence  of  lesion  development  in 
comparison  with  appropriate  controls,  equivalent  to  either  a  99%  or  100% 
neutralization activity for each experiment, respectively (7, 47, 48). 
Discussion 
Functionally  defined  mAb  directed  against  a  major  47  K  mol  wt  surface- 
exposed immunogen of T. pallidura were used to assign biological relevance to a 
potentially significant immunogen of the organism. The anti-47  K  monoclonal 
antibody possessed biological activities as assessed by both the TPI test (45) and 
the  in  vitro-in  vivo neutralization  test  (16).  Furthermore,  recent preliminary 
studies have shown the mAb to be capable of significantly blocking (-50%) the 
attachment of T. pallidura to tissue culture host cells (Dr. Thomas J. Fitzgerald, 
unpublished data, personal communication). Although this study and the work 
of others  (25-30)  have  previously  defined  several  antigens  of .the  organism, 
strategies  to  determine  or  assign  biological  relevance  to  any  one  particular 
antigen have thus far been lacking. 
Experiments  described  here  focused  upon  the  nature  of the  47  K  mol  wt 
immunogen  of T.  pallidum.  Antigens  of similar  molecular  weights  have  been 
described previously (25-30),  providing support for findings presented in  this 
study. Lukehart et al. (27) detected an antigen of 48 K mol wt using serum from 1414  MAJOR  SURFACE IMMUNOGEN  OF  T.  PALLIDUM 
hyperimmunized rabbits, while Hanff and colleagues (28, 29) reported an antigen 
of ~45  K  using serum from human syphilitic patients.  This  implies  that  the 
presence of the 47 K mol wt antigen is a specific result of the detection methods 
employed, and not merely an artifact of this particular study. 
Several other antigens of T. paUidum have been defined using serum from 
infected rabbits and immunized mice. Previous investigators (25-30) identified 
antigens of comparable molecular weights to all of the six antigens defined in 
this study; however, some exceptions should be noted. Baseman and Hayes (25) 
and  Alderete and  Baseman  (26)  used a  different combination of purification 
methods and intrinsic labeling techniques than  most other investigators.  This 
may explain their apparently dissimilar antigenic profile for T. paUidum. How- 
ever, Moskophidis et al. (30) recently employed labeling methods similar to those 
of Baseman et al.  (25), and yet obtained both similar and additional antigenic 
profiles to Hanff et al. (28, 29); it should be noted that the additional proteins 
are of molecular weights >50  K.  Baseman et al.  (25) also detected proteins in 
this molecular weight range. The fact that Moskophidis et al. (30) and Baseman 
et al. (25) used similar analytical systems and detected additional higher molecular 
weight proteins than other investigators surveyed, may indicate that the labeling 
methods used by Moskophidis et al. (30) and Baseman et al. (25) preferentially 
detected higher molecular weight antigens. Moskophidis et ai. (30) also detected 
antigens of molecular weights between 30  K and 50  K,  suggesting that either 
the method of detection and/or purification used by Baseman et al. (25) may be 
the source(s) of difference in antigenic profiles. Definitive conclusions about the 
variation among antigenic profiles cannot be drawn at this time, but the overall 
results  of most  investigators  appear  to  provide  a  rather  consistent  antigenic 
profile for T. paUidum. 
The anti-T, pallidum mAb was found to be directed against the 47 K mol wt 
immunogen  present  in  the  antigenic  profile  obtained  using  polyvalent  IRS 
reacted with ~25I-labeled, solubilized T. paUidum antigens. Studies to substantiate 
the specificity of this mAb for T. pallidum and the T. pallidum origin of the 47 
K  tool wt immunogen were accomplished using the host-indigenous nonpatho- 
gen, T. phagedenis biotype Reiter (the Reiter treponeme). The use of the Reiter 
treponeme as antigen in  immunoprecipitations or immunoblots demonstrated 
the lack of reactivity of the mAb with a Reiter protein. Furthermore, the use of 
various antisera absorbed exhaustively with the Reiter treponeme failed to detect 
a 47  K mol wt protein in immunoprecipitations using anti-T, pallidum immune 
rabbit serum as an antibody source. The fact that  immunoblot analysis using 
sonicated  treponemes also  failed to  detect  Reiter reactivity with  the  mAb is 
especially important; both intracellular and extracellular antigens are detected 
using this method. Consequently, the lack of mAb reactivity in the immunoblots 
indicates that the 47 K mol wt molecule is not found within the Reiter treponeme. 
The combined evidence suggests that the 47  K mol wt antigen is not found in 
nonpathogenic treponemes. Several other investigators have employed the Reiter 
treponeme as a strategy to screen for treponemai class antigens (27, 30, 31, 52), 
thus providing a consistent approach for surveying specific antigenic profiles of 
T. paUidum for cross-reactive treponemal activity. 
Results from this laboratory reported elsewhere (43) demonstrate that anti-47 JONES ET AL.  1415 
K immunogen monoclonal antibody is capable of reacting with two other virulent 
treponemes, T. pallidum subspecies pertenue  and T. pallidum subspecies endemicum 
(Bosnia A). This cross-reactivity was demonstrated with RIA, immunoblot anal- 
yses, and immuno-electron microscopy. These results, combined with those of 
this study, substantiate the specificity of the 47 K mol wt antigen for pathogenic 
treponemes. 
Additional  specificity studies  on  mAb  reactivity with  T.  pallidum  involved 
screening of the mAb to examine possible binding affinity for rabbit immuno- 
globulins (49).  Neither rabbit  IgG nor rabbit  IgM bound to anti-47  K  mAb, 
demonstrating the specificity for T. pallidum antigens, mAb was also nonreactive 
with rabbit  testicular tissue and rabbit  tissue antigens, as shown here and  in 
results previously reported (31). All assays employed thus far have demonstrated 
reactivity of the mAb specifically with Treponema pallidum. 
The 47  K mol wt protein has been shown to have several characteristics that 
suggest its importance as a  general or structural protein of T. pallidum, rather 
than  specifically as an  immunogen in  the infected host.  These characteristics 
include the localization  of the 47  K  protein as an abundant,  surface-exposed 
immunogenic protein of Treponema  pallidum; preliminary studies have also shown 
the  47  K  immunogen  to  be  sensitive  to  the  activities  of proteinase  K  and 
thermolysin  (data  not  shown).  The  fact  that  lactoperoxidase  labeling  of  T. 
pallidum results in the appearance of the characteristic antigenic profile further 
serves to establish the proteinaceous nature and surface localization of the antigen 
on T. pallidum cells. Other studies from this laboratory (43) have demonstrated 
that  mAb  against  the  47  K  tool  wt  antigen  can  bind  to  intact  treponemes, 
supporting the conclusion that the 47 K protein is indeed surface exposed. The 
density of the band observed at 47 K upon radioimmunoprecipitation and SDS- 
PAGE analysis is  also  indicative of the abundance of the protein  on  the cell 
surface. Corroboration of the abundance of this protein on the surface of the 
cell can be found by mAb reactivity in  the MHA-TP test.  The antigen  is  so 
abundant that T. paUidum-coated sheep erythrocytes agglutinate even using anti- 
47 K mAb, which are believed to cross-link antigens poorly due to their mono- 
specificity. 
Preliminary studies in  this laboratory with serum from human syphilitic pa- 
tients also have revealed the presence of an antigen corresponding to the 47 K 
antigen discussed above, further substantiating the ability of the 47  K  mol wt 
antigen to elicit a humoral immune response in the human host. Results of one 
human syphilitic serum trial using human late latent serum in radioimmunopre- 
cipitation can be visualized in lane 8 of Fig. 6. 
A  convincing argument for the importance of the role of the 47  K  mol wt 
immunogen in  pathogenesis was demonstrated through biological activities of 
the respective mAb directed against it. The ability of the mAb to immobilize T. 
pallidum in the TPI test provided initial evidence for significant biological activity 
of the mAb. Further evidence for the biological activity of the anti-47 K mAb is 
the fact that it is capable of significant blockage of T. pallidum attachment to 
host cells in tissue culture (12,  13;  Dr. Thomas J. Fitzgerald, personal commu- 
nication); in preliminary studies, the anti-47 K antibody repeatedly blocked 50% 
of T. pallidum from attaching to host cells. 1416  MAJOR  SURFACE IMMUNOGEN  OF  T.  PALL1DUM 
A striking correlation of mAb reactivity with importance to in vivo biological 
activity was provided using the in vitro-in vivo neutralization test of Bishop and 
Miller (16).  mAb was capable of causing delays in or absence of experimental 
lesion development equivalent to 99  and  100%  neutralization, respectively, as 
judged by the criteria of Turner and Hollander (7),  Magnuson et al. (47), and 
Fitzgerald  (48).  Although  the  ability  of mAb  to  neutralize  T.  pallidum  was 
unequivocal  in  these  experiments,  results  of other neutralization  assays  (not 
shown) indicated that prolonged storage of the mAb at 4 °C or the use of mAb 
at high final assay concentrations (>200 t~g/ml) abrogated its neutralizing activity. 
mAb  were  concentrated  using  several  different methods,  including  vacuum 
dialysis and membrane filtration, none of which were successful in maintaining 
the treponemicidal characteristic of the mAb in neutralization. Reasons for the 
loss of the neutralizing effect by these technical manipulations remain unclear; 
further experiments are  in  progress  to  determine why such losses  in  activity 
occur. In any event, it has been demonstrated that mAb stored at -70°C and 
used at a final assay concentration of 200 #g/ml in the neutralization test exhibits 
significant neutralizing activity. 
The  47  K  mol  wt  immunogen, with  the potential  of possessing  important 
biological  relevance,  provides  the  best  candidate  to  date  for  induction  of a 
protective immune state to Treponema pallidum in previously unexposed, suscep- 
tible  hosts.  Use of the anti-47  K  mol wt antibody to  evaluate its  efficacy in 
passive  protection  studies  and as  an  opsonin  for macrophage phagocytosis is 
currently underway. Of equal significance is the potential utilization of the mAb 
in affinity purification (53) to obtain purified "native" 47 K mol wt immunogen; 
for the first time, a method is provided to obtain purified protein antigen from 
T. paUidum that is free of contamination with host tissue.  Induction of active 
immunity with  this  purified  "native"  immunogen provides  among  the  most 
hopeful treponemal vaccine candidate to date. Based on the combined biochem- 
ical and biological data presented here, it  is  proposed that  the  47  K  mol wt 
immunogen represents a  major surface immunogen of 7". paUidum. Results of 
this study, therefore, provide a  rationale for further definitive studies on  the 
role  of the  T.  pallidum  immunogen in  the  pathogenesis of syphilis and  as  a 
potential vaccine candidate. 
Summary 
Radioimmunoprecipitation (RIP) analyses performed on  ~2~I-surface-labeled 
Treponema pallidum cells using various immune sera revealed the presence of six 
major surface antigens (immunogens) with apparent molecular weights of 47 K, 
36 K, 34 K, 32 K, 29 K, and 13 K. Among these, the 47 K surface antigen was 
most abundant. Radioimmunoprecipitation assays using l~5I-labeled T. phagedenis 
biotype Reiter or immunoblot analyses using the same strain, failed to reveal the 
presence  of the  47  K  mol  wt  antigen  in  the  representative  nonpathogenic 
treponeme. Preabsorption of anti-T, pallidum immune rabbit serum (IRS) with 
the Reiter organism did not remove anti-T, paUidum antibodies from immune 
serum that reacted with the 47  K mol wt immunogen or other immunogens of 
T. pallidum present in the characteristic antigenic profile. Monoclonal antibodies 
(mAb) directed specifically against the 47 K mol wt immunogen of T. paUidum JONES ET  AL.  1417 
also failed to react with an analogous 47  K  mol wt component in Treponema 
phagedenis biotype Reiter, further suggesting the unique presence of this antigen 
in pathogenic treponemes. The presence of the 47 K tool wt surface immunogen 
in pathogenic treponemes other than T. pallidum subspecies paUidum was also 
observed (43).  Anti-47 K immunogen mAb was nonreactive against rabbit IgG 
or IgM. 
mAb directed specifically against the 47 K mol wt immunogen of T. pallidum 
was examined for strategic functional activities. It was found to be reactive in 
the  microhemagglutination assay  for  T.  paUidum  antibodies,  the  T.  pallidum 
immobilization test,  and  was  found to  be  capable  of significant blockage  of 
attachment of virulent T.  pallidum  to  host  cells  in  tissue  culture.  Additional 
significant biological activity for the anti-47  K  tool wt immunogen mAb was 
revealed through results of the in vitro-in vivo neutralization test of Bishop and 
Miller, in which a  99%  or  100%  neutralizing activity was demonstrated. The 
combined data of this study suggest that the 47  K  tool wt immunogen of T. 
pallidum represents an abundant, immunodominant, surface-exposed immuno- 
gen possessing potential biological importance in  the pathogenesis and immu- 
nology of T. pallidum infection. These studies serve to establish the first func- 
tionally defined immunogen for T. pallidum,  which may represent the  major 
immunogen of the organism. 
We thank Dr. John R.  Kettman for helpful  discussions and continued interest  in this 
work, Dr. Ellen Vitetta for generously supplying highly purified immunological reagents, 
Dr. Philip A. Hanff for information on Percoli purification of treponemes  before publi- 
cation, Dr. Eric Hansen for helpful discussions and providing support facilities, Drs. Leon 
Eidels and David Hart for advice and discussions, Dr. ThomasJ. Fitzgerald for preliminary 
blockage of T. pallidum attachment studies, Dr.  Sheila A. Lukehart for independently 
confirming mAb 11 E3 reactivity with a 47-48-K antigen of T. pallidum in immunoblot 
analysis, Coleen Selland for monoclonal antibody maintenance  and purification,  Debra 
Twehous for T. pallidum maintenance and cultivation, and Alfred Urquhart for technical 
assistance in the conduct of the TPI test. Careful typing by Cindy Gresham was appreci- 
ated. 
Received for publication 22June 1984 and in revised  form 30July 1984. 
References 
1.  Sell, S., and S.J. Norris.  1983. The biology, pathology, and immunology of syphilis. 
In  International Review of Experimental  Pathology.  Academic Press, New York. 
203. 
2.  Fitzgerald, T.J.  1981. Pathogenesis and immunology of Treponeraa pallidum. Annu. 
Rev. Microbiol. 35:29. 
3.  Magnuson, H. J., E. W. Thomas, S. Oiansky, B. I. Kaplan, L. DeMello, and J. C. 
Cutler.  1956. Inoculation syphilis in human volunteers. Medicine (Baltimore). 35:33. 
4.  Rich, A.  R., A.  M.  Chesney, and T.  B. Turner.  1933. Bull. Johns Hopkins Hosp. 
69:53. 
5.  Hunter, J. 1812. A Treatise on Venereal Disease. 13th edition. London Press. 
6.  Turner, T. B., and D. H. Hollander.  1954. Studies on the mechanism of action of 
cortisone in experimental syphilis. Am. J. Syph. 38:371. 
7.  Turner, T. B., and D. H. Hollander.  1957. Biology of the Treponematoses.  World 
Health Organization,  Geneva. 1418  MAJOR SURFACE IMMUNOGEN OF  7".  PALLIDUM 
8.  Chesney, A. M. 1927. Immunity in syphilis.  Williams & Wilkins Co., Baltimore, MD. 
p.  1. 
9.  Schell, R. F., J. L. LeFrock, J. K. Chan, and O. Bagasra. 1980. LSH hamster model 
of syphilitic infection. Infect. Iramun. 28:909. 
10.  Pavia, C. S., J. D.  Folds, and J. B. Baseman.  1978. Cell-mediated immunity during 
syphilis. Br. J. Vener. Dis. 54:144. 
11.  ScheU, R. F., and D.  M.  Musher, editors.  1983. Pathogenesis and Immunology of 
Treponemal Infection. Marcel Dekker, Inc., New York. 
12.  Hayes, N.  B.,  K. E.  Muse, A.  M.  Collier, and J.  B.  Baseman.  1977.  Parasitism by 
virulent Treponema pallidum of host cell surfaces. Infect. Immun.  17:174. 
13.  Fitzgerald, T.J., R. C. Johnson, J. N. Miller, and J. A. Sykes. 1977. Characterization 
of the attachment of Treponema pallidum (Nichols strain) to cultured mammalian cells 
and the potential relationship of attachment to pathogenicity. Infect. Immun.  18:467. 
14.  Nelson, R.  A., and M.  M.  Mayer.  1949.  Immobilization of Treponema paUidura in 
vitro by antibody produced in syphilic infection.J. Exp. Med. 89:369. 
15.  Nelson, R. A.,Jr., andJ. A. Diesendruck. 1951. Studies on treponemal immobilizing 
antibodies in syphilis. J. Iramunol. 66:667. 
16.  Bishop, N. H., and J. N. Miller.  1976. Humoral immunity in experimental syphilis. 
II. The relationship of neutralizing factors in immune serum to acquired resistance. 
J. Immunol.  117:197. 
17.  Sepetjian, M., D. Salussola,  and J. Thivolet. 1973. Attempt to protect rabbits against 
experimental syphilis by passive immunization. Br. J. Vener. Dis. 49:335. 
18.  Perine, P. L., R. S. Weiser, and S.J. Klebanoff. 1973. Immunity to syphilis. I. Passive 
transfer in rabbits with hyperimmune serum. Infect. lmmun. 8:787. 
19.  Turner, T. B.,  P.  H. Hardy, B.  Newman, and E.  E.  Nell.  1973.  Effects of passive 
immunization on experimental syphilis in the rabbit.Johns Hopkins Med. J.  133:241. 
20.  Bishop, N. H., and J. N. Miller. 1976. Humoral immunity in experimental syphilis. 
I. The demonstration of resistance conferred by passive  immunization. J. tmmunol. 
117:191. 
21.  Weiser, R. S., D. Erickson, P. Perine, and N. N. Pearsall. 1976. Immunity to syphilis: 
passive transfer in rabbits using serial doses of immune serum. Infect. lramun. 13:1402. 
22.  Graves, S.  R., and J.  Alden.  1979.  Limited protection of rabbits against infection 
with Treponema pallidum by immune rabbit serum. Br. J. Vener. Dis. 55:399. 
23.  Azadegan,  A.  A.,  R.  F.  Schell, and J.  L.  LeFrock.  1983.  Immune serum confers 
protection against syphilitic infection on hamsters. Infect. Immun. 42:42. 
24.  Titus,  R.  G., and  R.  S.  Weiser.  1979.  Experimental syphilis  in the rabbit:  passive 
transfer of immunity with  immunoglobulin G  from immune serum. J.  Infect.  Dis. 
140:904. 
25.  Baseman,J. B., and E. C. Hayes. 1980. Molecular characterization of receptor binding 
proteins and immunogens of virulent Treponema pallidum. J. Exp. Med.  151:573. 
26.  Alderete, J.  F.,  and J.  B.  Baseman.  1980.  Surface  characterization  of virulent 
Treponema pallidum.  Infect. Immun. 30:814. 
27.  Lukehart, S. A., S. A. Baker-Zander, and E. R. Gubish. Identification of Treponema 
paUidum  antigens:  Comparison  with  a  nonpathogenic  treponeme.  J.  Immunol. 
129:833. 
28.  Hanff, P. A., J.  N.  Miller, and  M.  A.  Lovett.  1983.  Molecular characterization of 
common treponemal antigens. Infect. Immun. 40:825. 
29.  Hanff, P. A., T. E. Fehniger,J. N. Miller, and M. A. Lovett. 1982. Humoral immune 
response  in  human  syphilis  to  polypeptides  of Treponema  pallidum.  J.  lmmunol. 
129:1287. 
30.  Moskophidis, M., and F. Mfiller. 1984. Molecular analysis ofimmunoglobulins M and JONES  ET AL.  1419 
G in immune response to protein antigens of Treponema pallidum in human syphilis. 
Infect. Immun. 43:127. 
31.  Robertson, S.  M., J.  R.  Kettman, J.  N.  Miller, and M. V.  Norgard.  1982.  Murine 
monoclonal antibodies  specific  for  virulent  Treponema  pallidum  (Nichols).  Infect. 
Immun. 36:1076. 
32.  DiGiacomo, R. F., C. D. Talbert, S. A. Lukehart, S. A. Baker-Zander, andJ. Condon. 
1983. Treponema  paraluis-cuniculi infection in a commercial rabbitry: Epidemiology 
and serodiagnosis. Lab. Anim. Sci. 33:562. 
33.  Reif, A. E.  1969. Batch preparation of rabbit ~  (G) globulin with DEAE-cellulose. 
Immunochemistry.  6:723. 
34.  Hanff, P. A., N. H. Bishop, J. N. Miller, and M. A. Lovett. 1983. Humorai immune 
responses in experimental syphilis to polypeptides of Treponema pallidum. J. Immunol. 
131:1973. 
35.  Hanff,  P.  A.,  S. J.  Norris,  M.  A.  Lovett, and J.  N.  Miller.  1984.  Purification of 
Treponema  pallidum,  Nichols strain, by Percoll density gradient centrifugation. Sex. 
Transm. Dis. In press. 
36.  Hansen, E.J., C. F. Frisch, R. L. McDade,Jr., and K. H.Johnston. 1981. Identificauon 
of immunogenic outer membrane proteins of Haemophilus influenzae type b in the 
infant rat model system. Infect. lmmun.  32:1084. 
37.  Haustein, D. 1975. Effective radioiodination by lactoperoxidase and solubilization of 
cell-surface proteins of cultured murine T lymphoma cells. J. lmmunol. Methods. 7:25. 
38.  Hunter,  D.  M.,  and  F.  C.  Greenwood.  1962.  Preparation of 131I-labelled human 
growth hormone of high specific activity. Nature (Lond.). 194:495. 
39.  Kessler, S. W.  1976. Cell membrane antigen isolation with the staphlycoccal protein 
A-antibody adsorbent. J. Immunol.  117:1482. 
40.  Laemmli, U.  K.  1970.  Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature (Lond.). 227:680. 
41.  Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins 
from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. 
Proc. Natl. Acad.  Sci. USA. 76:4350. 
42.  Burnette,  W.  N.  1980.  Western  blotting and electrophoretic transfer of proteins 
from sodium dodecyi sulfate-polyacrylamide gels to unmodified nitrocellulose and 
radiographic detection with antibody and radioiodinated protein A. Anal.  Biochem. 
112:195. 
43.  Marchitto, K. S., S. A. Jones, R. F. Schell, P. L. Holmans, and M. V. Norgard. 1984. 
Monoclonal antibody analysis  of specific antigenic  similarities  among  pathogenic 
Treponema pallidum subspecies, lnfect.  Immun. 45:660. 
44.  Hjelm, H., K. Hjelm, and J. Sjoquist. 1972. Protein A from staphylcoceus aureus.  Its 
isolation by affinity chromatography and its use as an immunosorbent for isolation 
of immunoglobulins. FEBS (Fed. Eur. Biochem. Soc.) Left.  28:73. 
45.  Centers  for  Disease  Control.  1964.  Manual  of Tests  for  Syphilis.  United  States 
Department of Health, Education, and Welfare. Public Health Service, N.C.D.C., 
Atlanta, GA. 
46.  Tight, R. R., and A. C. White.  1980. Quantitative microhemagglutination assay for 
Treponema pallidum antibody in experimental syphilis. Br. J. Vener. Dis. 56:291. 
47.  Magnuson,  H. J.,  H.  Eagle,  and  R.  Fleischman.  1948.  The  minimal  infectious 
inoculum of Spirochaeta  pallida  (Nichols strain) and a  consideration of its rate of 
multiplication in vivo. Am. J. Syph. Gonor. Verier. Dis. 32:1. 
48.  Fitzgerald,  T. J.  1981.  Accelerated lesion  development in  experimental syphilis. 
Infect. lmmun.  34:478. 1420  MAJOR SURFACE IMMUNOGEN OF  T.  PALLIDUM 
49.  Logan, L. C. 1974. Rabbit globulin and antiglobulin factors associated with Treponema 
pallidum grown in rabbits. Br. J. Vener. Dis. 50:421. 
50.  Alderete, J. F., and J. B. Baseman. 1979. Surface-associated host proteins on virulent 
Treponema paUidum. Infect. Immun.  26:1048. 
51.  Nisonoff, A., J.  E.  Hopper, and S.  B.  Spring.  1975.  In The Antibody Molecule. 
Academic Press, Inc., New York. 
52.  Pedersen,  N.  S.,  N.  H.  Axelsen, and C.  S.  Pedersen.  1981.  Antigenic analysis  of 
Treponema pallidum:  Cross-reaction between individual antigens of T. paUidum and 
T. reiter. Scand. J. Immunol.  13:143. 
53.  Cuatrecasas,  P.,  and  C.  B.  Anfinsen.  1971.  Affinity chromatography. Annu.  Rev. 
Biochem. 40:259. 